Report cover image

Global Cancer Diagnostics Market Size- By Product, By Type, By Application, By End-User, By Test Type, By Coverage- Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Publisher SPER Market Research Pvt. Ltd.
Published Jul 01, 2025
Length 244 Pages
SKU # SPER20295376

Description

Cancer Diagnostics Market Introduction and Overview

According to SPER market research, ‘Global Cancer Diagnostics Market Size- By Product, By Type, By Application, By End-User, By Test Type, By Coverage- Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Cancer Diagnostics Market is predicted to reach 204.98 billion by 2034 with a CAGR of 6.43%.

Cancer diagnostics is the identification and diagnosis of cancer in the body using a range of medical tests and technology. Biopsies, advanced molecular diagnostics (genetic testing), laboratory testing (blood, urine, and tissue analysis), imaging (MRI, CT scans, X-rays), and other techniques are employed. A prompt and precise diagnosis helps define the type, location, and stage of cancer, impacting treatment decisions and improving patient outcomes.

Restraints:
The market for cancer diagnostics is confronted with a number of obstacles despite its optimistic outlook. Particularly in areas with low and intermediate incomes, accessibility is restricted by the high expenses of sophisticated diagnostic tools and treatments. Complex reimbursement schemes and delayed regulatory clearances are further barriers to the use of innovative diagnostic technology.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered

By Product, By Type, By Application, By End User, By Test Type, By Coverage

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Abbott, BD, F. Hoffmann-La Roche Ltd, GE Healthcare, Hologic, Inc, Illumina, Inc, Koninklijke Philips N.V (Philips), QIAGEN, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc.

Global Cancer Diagnostics Market Segmentation:

By Product:
Based on the Product, Global Cancer Diagnostics Market is segmented as; Consumables, Instruments, Services.

By Type: Based on the Type, Global Cancer Diagnostics Market is segmented as; IVD, LDT, Imaging.

By Application:
Based on the Application, Global Cancer Diagnostics Market is segmented as; Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Prostate Cancer, Skin Cancer, Blood Cancer, Kidney Cancer, Liver Cancer, Pancreatic Cancer, Ovarian Cancer, Others.

By End-User: Based on the End User, Global Cancer Diagnostics Market is segmented as; Hospitals, Laboratories, Others.

By Test Type: Based on the Test Type, Global Cancer Diagnostics Market is segmented as; Biopsy, Others.

By Coverage: Based on the Coverage, Global Cancer Diagnostics Market is segmented as; Public Insurance, Private Insurance.

By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

244 Pages
1. Introduction
1.1.Scope of the report
1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data
2.1.2.Primary Data
2.1.3.SPER’s internal database
2.1.4.Premium insight from KOL’s
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers
4.1.2.Restraints
4.1.3.Opportunities
4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths
5.1.2.Weaknesses
5.1.3.Opportunities
5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape
5.2.2.Economic Landscape
5.2.3.Social Landscape
5.2.4.Technological Landscape
5.2.5.Environmental Landscape
5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers
5.3.2.Bargaining power of buyers
5.3.3.Threat of Substitute
5.3.4.Threat of new entrant
5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Cancer Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cancer Diagnostics Market
7.Global Cancer Diagnostics Market, By Product (USD Million) 2021-2034
7.1.Instruments
7.1.1.Pathology-based Instruments
7.1.1.1.Slide Staining Systems
7.1.1.2.Tissue Processing Systems
7.1.1.3.Cell Processors
7.1.1.4.PCR Instruments
7.1.1.5.NGS Instruments
7.1.1.6.Microarrays
7.1.1.7.Other Pathology-based Instruments
7.1.2.Imaging Instruments
7.1.3.Others
7.2.Consumables
7.2.1.Antibodies
7.2.2.Kits & reagents
7.2.3.Probes
7.2.4.Others
7.3.Services
8.Global Cancer Diagnostics Market, By Type (USD Million) 2021-2034
8.1. IVD
8.1.1.By Type
8.1.1.1.Diagnosis
8.1.1.2.Early Detection
8.1.1.3.Therapy Selection
8.1.1.4.Monitoring
8.1.2.By Technology
8.1.2.1.Polymerase Chain Reaction (PCR)
8.1.2.2.In Situ Hybridization (ISH)
8.1.2.3.Immunohistochemistry (IHC)
8.1.2.4.Next-generation Sequencing (NGS)
8.1.2.5.Microarrays
8.1.2.6.Flow Cytometry
8.1.2.7.Immunoassays
8.1.2.8.Other IVD Testing Technologies
8.2.LDT
8.3.Imaging
8.3.1.Magnetic Resonance Imaging (MRI)
8.3.2.Computed Tomography (CT)
8.3.3.Positron Emission Tomography (PET)
8.3.4.Mammography
8.3.5.Ultrasound
8.3.6.Others
9.Global Cancer Diagnostics Market, By Application (USD Million) 2021-2034
9.1.Breast Cancer
9.2.Colorectal Cancer
9.3.Cervical Cancer
9.4.Lung Cancer
9.5.Prostate Cancer
9.6.Skin Cancer
9.7.Blood Cancer
9.8.Kidney Cancer
9.9.Liver Cancer
9.10.Pancreatic Cancer
9.11.Ovarian Cancer
9.12.Others
10.Global Cancer Diagnostics Market, By End User (USD Million) 2021-2034
10.1.Hospitals
10.2.Laboratories
10.3.Others
11.Global Cancer Diagnostics Market, By Test Type (USD Million) 2021-203
11.1.Biopsy
11.1.1.Fine-needle Aspiration
11.1.2.Core Biopsy
11.1.3.Surgical Biopsy
11.1.4.Skin Biopsy /Punch Biopsy
11.1.5.Others
11.2.Others
12.Global Cancer Diagnostics Market, By Coverage (USD Million) 2021-2034
12.1.Public Insurance
12.2.Private Insurance
13.Global Cancer Diagnostics Market, (USD Million) 2021-2034
13.1.Global Cancer Diagnostics Market Size and Market Share
14.Global Cancer Diagnostics Market, By Region, (USD Million) 2021-2034
14.1.Asia-Pacific
14.1.1.Australia
14.1.2.China
14.1.3.India
14.1.4.Japan
14.1.5.South Korea
14.1.6.Rest of Asia-Pacific
14.2.Europe
14.2.1.France
14.2.2.Germany
14.2.3.Italy
14.2.4.Spain
14.2.5.United Kingdom
14.2.6.Rest of Europe
14.3.Middle East and Africa
14.3.1.Kingdom of Saudi Arabia
14.3.2.United Arab Emirates
14.3.3.Qatar
14.3.4.South Africa
14.3.5.Egypt
14.3.6.Morocco
14.3.7.Nigeria
14.3.8.Rest of Middle-East and Africa
14.4.North America
14.4.1.Canada
14.4.2.Mexico
14.4.3.United States
14.5.Latin America
14.5.1.Argentina
14.5.2.Brazil
14.5.3.Rest of Latin America
15.Company Profile
15.1.Abbott
15.1.1.Company details
15.1.2.Financial outlook
15.1.3.Product summary
15.1.4.Recent developments
15.2.BD
15.2.1.Company details
15.2.2.Financial outlook
15.2.3.Product summary
15.2.4.Recent developments
15.3.F. Hoffmann-La Roche Ltd
15.3.1.Company details
15.3.2.Financial outlook
15.3.3.Product summary
15.3.4.Recent developments
15.4.GE Healthcare
15.4.1.Company details
15.4.2.Financial outlook
15.4.3.Product summary
15.4.4.Recent developments
15.5.Hologic, Inc
15.5.1.Company details
15.5.2.Financial outlook
15.5.3.Product summary
15.5.4.Recent developments
15.6.Illumina, Inc
15.6.1.Company details
15.6.2.Financial outlook
15.6.3.Product summary
15.6.4.Recent developments
15.7.Koninklijke Philips N.V. (Philips)
15.7.1.Company details
15.7.2.Financial outlook
15.7.3.Product summary
15.7.4.Recent developments
15.8.QIAGEN
15.8.1.Company details
15.8.2.Financial outlook
15.8.3.Product summary
15.8.4.Recent developments
15.9.Siemens Healthcare GmbH
15.9.1.Company details
15.9.2.Financial outlook
15.9.3.Product summary
15.9.4.Recent developments
15.10.Thermo Fisher Scientific, Inc
15.10.1.Company details
15.10.2.Financial outlook
15.10.3.Product summary
15.10.4.Recent developments
15.11.Others
16.Conclusion
17.List of Abbreviations
18.Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us